Get started
Author

John S. Pears

Observed names: J Pears, J S Pears, J. Pears, J. S. PEARS, J.S Pears, J.S. PEARS, J.S. Pears, JS PEARS, JS Pears, John Pears, John S Pears
Observed institutions: Linköping University, AstraZeneca (United Kingdom), University of Helsinki, University of Dundee, University of Washington, Sahlgrenska University Hospital, Ninewells Hospital, Gentofte Hospital, Linköping University Hospital
OpenAlex ID: A5112372464
Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia
2001 · Anders G Olsson, John Pears, et al. · The American Journal of Cardiology · 193
Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia
2002 · Anders G. Olsson, Helge Istad, et al. · American Heart Journal · 177
Rosuvastatin-Induced Arrest in Progression of Renal Disease
2004 · Donald G. Vidt, Michael D. Cressman, et al. · Cardiology · 153
Safety of rosuvastatin
2004 · James Shepherd, Donald B. Hunninghake, et al. · The American Journal of Cardiology · 139
Using controlled clinical trials to learn more about acute drug-induced liver injury
2008 · Paul B. Watkins, Paul J. Seligman, et al. · Hepatology · 114
PDF
Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia
2003 · Muriel J. Caslake, Grace Stewart, et al. · Atherosclerosis · 86
Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin
2003 · Daniel J Rader, Michael H Davidson, et al. · The American Journal of Cardiology · 84
A case study using the PrOACT‐URL and BRAT frameworks for structured benefit risk assessment
2015 · Richard Nixon, Christoph Dierig, et al. · Biometrical Journal · 45
Long-Term Weight Changes in Treated Hyperthyroid and Hypothyroid Patients
1990 · J. Pears, R. T. Jung, et al. · Scottish Medical Journal · 37
A case of skin hyperpigmentation due to α-MSH hypersecretion
1992 · J.S. PEARS, R.T. JUNG, et al. · British Journal of Dermatology · 27
Audit of the quality of hospital discharge data.
1992 · J Pears, V Alexander, et al. · PubMed · 24
Use of 24 h ambulatory ECG recordings in the assessment of new chemical entities in healthy volunteers.
1995 · JC Stinson, JS Pears, et al. · British Journal of Clinical Pharmacology · 23
PDF
Glycogen Storage Disease Diagnosed in Adults
1992 · JS PEARS, RT JUNG, et al. · QJM · 23
Pharmacodynamics of new HMG-CoA reductase inhibitor ZD4522 in patients with primary hypercholesterolaemia
2000 · A.G Olsson, J.S Pears, et al. · Atherosclerosis · 15
Benign Intracranial Hypertension Associated with Danazol
1990 · J. Pears, P. A. Sandercock · Scottish Medical Journal · 14
A Systematic Approach to Preclinical and Clinical Safety Biomarker Qualification Incorporating Bradford Hill's Principles of Causality Association
2010 · R K Chetty, J S Ozer, et al. · Clinical Pharmacology & Therapeutics · 10
Glucose-6-phosphatase in normal adult human intestinal mucosa
1992 · John Pears, Roland T. Jung, et al. · Clinical Science · 10
Amiloride activation of hepatic microsomal glucose-6-phosphatase; activation of T1?
1989 · John Pears, Roland T. Jung, et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 9
Study design for a randomized, double-blind trial to assess the effect of 24 months of dosing with rosuvastatin on progression of carotid artery atheroma in moderately hypercholesterolemic patients with asymptomatic carotid stenois
2001 · T.S. Hatsukami, X-Q. Zhao, et al. · Atherosclerosis Supplements · 8
Reactive Hypoglycaemia in Association with Disordered Islet Function and Abnormal Hepatic Glucose‐6‐Phosphatase Activity: Response to Diazoxide
1991 · J. Pears, R. T. Jung, et al. · Diabetic Medicine · 8
Cytosolic phenol and steroid sulphotransferase activities are decreased in a sex-dependent manner in streptozotocin-induced diabetic rats
1990 · Michael W.H. Coughtrie, John Pears, et al. · Biochemical Pharmacology · 8
Rosuvastatin produces significantly greater reductions in low-density lipoprotein cholesterol and more patients achieve treatment goals compared with simvastatin
2003 · Ian Hamilton-Craig, Ernst Schaefer, et al. · Heart Lung and Circulation · 6
Lifestyle-Gene-Drug Interactions in Relation to the Metabolic Syndrome
2005 · Len Storlien, Xu Feng Huang, et al. · KARGER eBooks · 4
2P-0613 Safety profile of rosuvastatin 10–40 mg in an intergnational phase II/III clinical trial program
2003 · J. Shepherd, D.B. Hunninghake, et al. · Atherosclerosis Supplements · 2
Fatal Hypersensitivity Reaction to Sulphasalazine
1989 · J. S. PEARS, K. D. MORLEY · Rheumatology · 1
Works count: 27
Citation count: 1,220
H-index: 14
I10-index: 17
Year
Topic
Type